New York, New York (PRWEB) February 08, 2015
Thousands of vaginal mesh lawsuits (http://www.vaginalmeshlawsuit2015.com/) filed against C.R. Bard, Inc. continue to move forward in the federal multidistrict litigation underway in U.S District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order issued on January 30th, the Court has established new deadlines for the filing of certain motions is Wave 1 and Wave 2 cases, as well as replies and responses to those motions. (In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2187)
Our Firm is representing numerous women who allegedly suffered serious transvaginal mesh complications due to products manufactured by C.R. Bard. We are pleased to see these cases moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices including transvaginal mesh. The Firm is offering free and confidential case evaluations to women who were allegedly harmed by products used to treat stress urinary incontinence and pelvic organ prolapse.
Vaginal Mesh Litigation
According to court documents, more than 10,000 vaginal mesh lawsuits have been filed in the Southern District of West Virginia on behalf of women who allegedly suffered mesh erosion, organ damage, chronic pain and other painful complications following implantation of the companys pelvic mesh products. Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, is serving on the Plaintiffs Steering Committee for the federal Boston Scientific litigation.
Court records indicate that the litigation involving transvaginal mesh has been growing since 2008, when the U.S. Food and Drug Administration (FDA) first warned about the risk for serious transvaginal mesh complications. In July 2011, the agency issued a second alert stating there had been a five-fold increase in mesh complication reports since that earlier communication was releases. The FDA also noted that the occurrence of such complications among women who received the devices for prolapse repair was not rare, which was a change from the position it had taken previously.*
According to court filings, more than 67,000 transvaginal mesh lawsuits are currently pending in several litigations underway in the U.S. District Court, Southern District of West Virginia. In addition to his work with the Boston Scientific proceeding, Mr. Grand is an active member of the Plaintiffs Steering Committees in the remaining federal proceedings: In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation – MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation – MDL No. 2326; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation – MDL No. 2327; Coloplast Corp. Pelvic Support Systems Products Liability Litigation – MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2440; In Re: Neomedic Pelvic Repair System Products Liability Litigation – MDL No. 2511.
Mr. Grand was also appointed Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon mesh lawsuits in New Jersey Superior Court. In addition, he served as a member of the plaintiffs trial team for the states first Ethicon trial, which ended in March 2013 with an $ 11 million verdict for a woman who experienced vaginal mesh complications related to the Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Women who were implanted with vaginal mesh to treat pelvic organ prolapse or stress urinary incontinence may be entitled to compensation if they suffered mesh erosion, chronic pain, organ damage or any other serious complications that were allegedly caused by their implant. To learn more about filing a transvaginal mesh lawsuit, please visit Bernstein Liebhard LLP’s website or the firm’s Facebook page: https://www.facebook.com/meshlawsuit. To arrange for a free legal consultation, please call 800-511-5092.
*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm, FDA, July 2011
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016